Christoph M. Bucher
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors.
Journal: Journal for immunotherapy of cancer
Published: October 06, 2023
Mocravimod, a S1P receptor modulator, increases T cell counts in bone marrow biopsies from patients undergoing allogeneic hematopoietic stem cell transplantation.
Journal: Cellular immunology
Published: December 21, 2022
Mitigating Drug-Target-Drug Complexes in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Switch C5 Inhibitors.
Journal: Clinical pharmacology and therapeutics
Published: September 26, 2022
Mocravimod, a Selective Sphingosine-1-Phosphate Receptor Modulator, in Allogeneic Hematopoietic Stem Cell Transplantation for Malignancy.
Journal: Transplantation and cellular therapy
Published: August 30, 2022
Sphingosine-1-phosphate Receptor-1 Agonist Averts the De Novo Generation of Autoreactive T-cells in Murine Acute Graft-versus-Host Disease.
Journal: HemaSphere
Published: March 11, 2021
Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria.
Journal: Haematologica
Published: August 06, 2020
Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis.
Journal: The Lancet. Haematology
Published: February 03, 2020
The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria.
Journal: Blood
Published: September 19, 2019
Impact of drains on nausea and vomiting after thyroid and parathyroid surgery: a randomized controlled trial.
Journal: Langenbeck's archives of surgery
Published: March 29, 2019
Baseline calprotectin fails to predict incidence of acute gastrointestinal graft vs. host disease: a prospective study.
Journal: Bone marrow transplantation
Published: March 08, 2018
High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease.
Journal: Bone marrow transplantation
Published: March 07, 2018
Beneficial role of increased FOXP3+ regulatory T-cells in acute myeloid leukaemia therapy response.
Journal: British journal of haematology
Published: June 28, 2017
Last Updated: 09/26/2026